Market Overview:
The global biopsy guidance systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, technological advancements in biopsy guidance systems, and rising demand for minimally invasive procedures. Based on type, the global biopsy guidance systems market is segmented into stereotactic guided biopsy, ultrasound guided biopsy, and MRI guided biopsy.
Product Definition:
Biopsy guidance systems are used to help medical professionals place biopsies more accurately. This is important because it helps ensure that the biopsy sample is taken from the correct location and that the tissue is properly sampled.
Stereotactic Guided Biopsy:
Stereotactic guided biopsy (SGB) is a minimally invasive procedure used to remove lesions or cancer cells from the body. It uses high-energy waves to destroy the targeted tissue without harming surrounding areas. The procedure has gained popularity due to its several advantages such as reduced pain, decreased risk of infection, and lower damage to nearby healthy tissues.
Ultrasound Guided Biopsy:
Ultrasound-guided biopsy is a diagnostic procedure used for the removal of abnormal cells from the body. It uses high frequency sound waves to create images of internal organs and tissues, which are then fed to a computer for analysis. Biopsy guidance systems use this data along with other inputs such as CT or MRI scans and patient history to guide a needle directly into the required tissue region for taking samples.
Application Insights:
Based on application, the global biopsy guidance systems market is segmented into hospitals, specialty clinics, diagnostic centers, research and academic institutes and other sites. Hospitals held the largest share in 2017 owing to factors such as increasing incidence of cancer which requires surgical intervention coupled with an increase in number of surgeries. As a result, hospitals are adopting various advanced technologies that help diagnose diseases with greater accuracy.
The specialty clinics are also expected to grow at a lucrative rate during the forecast period due to growing awareness about early diagnosis coupled with technological advancements for better precision while diagnosing various cancers. For instance; In June 2018; The Institute for Cancer Research at University College London (UCL) launched a new £6 million facility that will enable it to develop innovative new ways of treating lung and breast cancer patients using immunotherapy drugs combined with radiotherapy treatments.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing incidence of cancer, rising adoption of technologically advanced products, and presence of major players in this region. For instance, as per the National Cancer Institute (NCI), there were 1.5 million new cases diagnosed globally in 2016 and 60% of these cases were reported from North America.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure & availability; rising prevalence/incidence; awareness about early diagnosis; and growing investments by governments & private organizations for research on cancer biology & treatment options.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for biopsy guidance systems, as they help in accurate and timely diagnosis of cancer.
- Technological advancements: The development of new and innovative technologies is helping to boost the growth of the biopsy guidance systems market. For instance, recent advancements in image-guided surgery are helping to improve the accuracy and precision of biopsies.
- Rising awareness about early diagnosis and treatment: There is a growing awareness among people about the importance of early diagnosis and treatment for various diseases, including cancer. This is driving demand for biopsy guidance systems, as they help in accurate diagnosis at an early stage.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biopsy Guidance Systems Market Research Report
By Type
Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy
By Application
Hospitals, Specialty Clinics, Diagnostic Centers, Research and Academic Institutes, Others
By Companies
BD, Hologic, Inc, Devicor Medical Products, Inc, B. Braun Melsungen AG, Boston Scientific Corporation, Planmed Oy, BD
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Biopsy Guidance Systems Market Report Segments:
The global Biopsy Guidance Systems market is segmented on the basis of:
Types
Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Diagnostic Centers, Research and Academic Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Hologic, Inc
- Devicor Medical Products, Inc
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Planmed Oy
- BD
Highlights of The Biopsy Guidance Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stereotactic Guided Biopsy
- Ultrasound Guided Biopsy
- MRI Guided Biopsy
- By Application:
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Research and Academic Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biopsy Guidance Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A biopsy guidance system is a type of medical technology that helps doctors perform accurate and safe biopsies. These systems typically include a camera, navigation software, and sensors that help the doctor determine where to make the biopsy.
Some of the key players operating in the biopsy guidance systems market are BD, Hologic, Inc, Devicor Medical Products, Inc, B. Braun Melsungen AG, Boston Scientific Corporation, Planmed Oy, BD.
The biopsy guidance systems market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopsy Guidance Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biopsy Guidance Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biopsy Guidance Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biopsy Guidance Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biopsy Guidance Systems Market Size & Forecast, 2018-2028
4.5.1 Biopsy Guidance Systems Market Size and Y-o-Y Growth
4.5.2 Biopsy Guidance Systems Market Absolute $ Opportunity
Chapter 5 Global Biopsy Guidance Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biopsy Guidance Systems Market Size Forecast by Type
5.2.1 Stereotactic Guided Biopsy
5.2.2 Ultrasound Guided Biopsy
5.2.3 MRI Guided Biopsy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biopsy Guidance Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biopsy Guidance Systems Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Diagnostic Centers
6.2.4 Research and Academic Institutes
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biopsy Guidance Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biopsy Guidance Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biopsy Guidance Systems Analysis and Forecast
9.1 Introduction
9.2 North America Biopsy Guidance Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biopsy Guidance Systems Market Size Forecast by Type
9.6.1 Stereotactic Guided Biopsy
9.6.2 Ultrasound Guided Biopsy
9.6.3 MRI Guided Biopsy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biopsy Guidance Systems Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Diagnostic Centers
9.10.4 Research and Academic Institutes
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biopsy Guidance Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Biopsy Guidance Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biopsy Guidance Systems Market Size Forecast by Type
10.6.1 Stereotactic Guided Biopsy
10.6.2 Ultrasound Guided Biopsy
10.6.3 MRI Guided Biopsy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biopsy Guidance Systems Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Diagnostic Centers
10.10.4 Research and Academic Institutes
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biopsy Guidance Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biopsy Guidance Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biopsy Guidance Systems Market Size Forecast by Type
11.6.1 Stereotactic Guided Biopsy
11.6.2 Ultrasound Guided Biopsy
11.6.3 MRI Guided Biopsy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biopsy Guidance Systems Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Diagnostic Centers
11.10.4 Research and Academic Institutes
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biopsy Guidance Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Biopsy Guidance Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biopsy Guidance Systems Market Size Forecast by Type
12.6.1 Stereotactic Guided Biopsy
12.6.2 Ultrasound Guided Biopsy
12.6.3 MRI Guided Biopsy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biopsy Guidance Systems Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Diagnostic Centers
12.10.4 Research and Academic Institutes
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biopsy Guidance Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biopsy Guidance Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biopsy Guidance Systems Market Size Forecast by Type
13.6.1 Stereotactic Guided Biopsy
13.6.2 Ultrasound Guided Biopsy
13.6.3 MRI Guided Biopsy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biopsy Guidance Systems Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Diagnostic Centers
13.10.4 Research and Academic Institutes
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biopsy Guidance Systems Market: Competitive Dashboard
14.2 Global Biopsy Guidance Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD
14.3.2 Hologic, Inc
14.3.3 Devicor Medical Products, Inc
14.3.4 B. Braun Melsungen AG
14.3.5 Boston Scientific Corporation
14.3.6 Planmed Oy
14.3.7 BD
